Iran has produced a recombinant factor VIII drug, and hopes to mass-produce the medicine in the current Iranian calendar year, which started on March 20, 2016.
The drug, also dubbed AHF, is one of the proteins involved in blood coagulation. It is a protein which helps blood coagulation in consecutive reactions.
Lack of the factor causes Hemophilia A.
While there are over 100 recombinant drugs in the world, Factor VIII is one of the most complicated ones.
Iranian researchers made Coagulation factor 8 through a recombinant method. The researchers used biotechnology and genetic engineering and produced the efficient gene.
The product was processed in a reactor through biotechnology and biotechnology engineering.
The country would save at least $60m if it could mass-produce the drug.
For the first time in Iran's aviation history, a flight carrying an all-female crew and…
Tehran’s Cyber Police Chief, Brigadier General Davood Moazzami Goudarzi, announced a crackdown on individuals causing…
Doha will stop gas shipments to the EU if member states enforce new legislation on…
At least 15,000 British soldiers left the country's Armed Forces between November 2023 and October…
Journalists have identified the names of 84,761 Russian soldiers who died during the war in…
The United States Navy has inadvertently shot down its own F/A-18 fighter jet in a…